Oxidative Phosphorylation Dysfunction Modifies the Cell Secretome.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
10 May 2020
Historique:
received: 18 03 2020
revised: 29 04 2020
accepted: 09 05 2020
entrez: 14 5 2020
pubmed: 14 5 2020
medline: 9 2 2021
Statut: epublish

Résumé

Mitochondrial oxidative phosphorylation disorders are extremely heterogeneous conditions. Their clinical and genetic variability makes the identification of reliable and specific biomarkers very challenging. Until now, only a few studies have focused on the effect of a defective oxidative phosphorylation functioning on the cell's secretome, although it could be a promising approach for the identification and pre-selection of potential circulating biomarkers for mitochondrial diseases. Here, we review the insights obtained from secretome studies with regard to oxidative phosphorylation dysfunction, and the biomarkers that appear, so far, to be promising to identify mitochondrial diseases. We propose two new biomarkers to be taken into account in future diagnostic trials.

Identifiants

pubmed: 32397676
pii: ijms21093374
doi: 10.3390/ijms21093374
pmc: PMC7246988
pii:
doi:

Substances chimiques

Biomarkers 0
DNA, Mitochondrial 0
FGF21 protein, human 0
GDF15 protein, human 0
Growth Differentiation Factor 15 0
IL6 protein, human 0
Interleukin-6 0
Vascular Endothelial Growth Factor A 0
Fibroblast Growth Factors 62031-54-3

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : FIS-PI17/00021 and PI17/00166
Organisme : Fundación Mutua Madrileña
ID : MMA17/01
Organisme : Precipita-FECYT crowdfunding program
ID : PR194
Organisme : Gobierno de Aragón
ID : Grupos Consolidados B33_17R
Organisme : Gobierno de Aragón
ID : FEDER 2014-2020 "Construyendo Europa desde Aragón"
Organisme : Asociación de Enfermos de Patología Mitocondrial
ID : (AEPMI)
Organisme : Plan Nacional de I + D + I and Instituto de Salud Carlos III (ISCIII) Subdirección General de Evaluación y Fomento de la Investigación Sanitaria
ID : PI19/0122
Organisme : co-funded with European Regional Development Fund (ERDF)
ID : "A way to achieve Europe".

Références

Science. 2008 May 2;320(5876):661-4
pubmed: 18388260
Biosci Rep. 2017 Sep 27;37(5):
pubmed: 28831023
Proteomics. 2012 Feb;12(4-5):722-35
pubmed: 22247067
PLoS One. 2015 Apr 17;10(4):e0124362
pubmed: 25884837
Sci Rep. 2019 Feb 28;9(1):3096
pubmed: 30816242
Redox Biol. 2017 Oct;13:244-254
pubmed: 28600981
Methods Mol Biol. 2017;1662:45-58
pubmed: 28861816
Antimicrob Agents Chemother. 2010 Jan;54(1):280-7
pubmed: 19805555
Cell. 2008 Jul 11;134(1):112-23
pubmed: 18614015
Aging Cell. 2007 Oct;6(5):619-30
pubmed: 17651460
Mol Cell Biol. 2015 Oct 26;36(1):184-96
pubmed: 26503783
PLoS One. 2011;6(12):e29691
pubmed: 22216345
Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1093-9
pubmed: 19423864
Biochimie. 2013 Dec;95(12):2286-96
pubmed: 23880643
FEBS J. 2013 Feb;280(4):1039-50
pubmed: 23253816
Neurology. 2014 Jul 8;83(2):125-33
pubmed: 24907231
Acta Derm Venereol. 1991;71(2):93-8
pubmed: 1675538
Am J Hum Genet. 2001 Dec;69(6):1186-97
pubmed: 11605159
J Clin Endocrinol Metab. 2012 Apr;97(4):1375-82
pubmed: 22344195
Nature. 1981 Apr 9;290(5806):457-65
pubmed: 7219534
PLoS One. 2016 Feb 11;11(2):e0148709
pubmed: 26867126
Nature. 2012 Nov 15;491(7424):374-83
pubmed: 23151580
No To Hattatsu. 1989 Jul;21(4):369-73
pubmed: 2551357
Mitochondrion. 2015 Jan;20:34-42
pubmed: 25446397
Nat Genet. 2000 Oct;26(2):176-81
pubmed: 11017072
J Cell Physiol. 2008 Dec;217(3):686-92
pubmed: 18651567
Cell. 2018 Mar 22;173(1):117-129.e14
pubmed: 29570992
Liver Transpl. 2018 May;24(5):595-605
pubmed: 29476704
JIMD Rep. 2015;24:69-81
pubmed: 25967227
Br J Dermatol. 1994 Aug;131(2):250-6
pubmed: 7917990
Biochem J. 2014 Oct 15;463(2):191-9
pubmed: 25055037
Nat Genet. 2001 Jul;28(3):223-31
pubmed: 11431692
Cytokine Growth Factor Rev. 2013 Aug;24(4):373-84
pubmed: 23787157
Dis Model Mech. 2015 Nov;8(11):1441-55
pubmed: 26398948
J Endocrinol. 2017 Apr;233(1):105-118
pubmed: 28184000
Neurology. 2016 Nov 29;87(22):2290-2299
pubmed: 27794108
Mitochondrion. 2019 Sep;48:11-15
pubmed: 30738201
J Inherit Metab Dis. 2011 Apr;34(2):277-82
pubmed: 20941643
Lancet Neurol. 2010 Aug;9(8):829-40
pubmed: 20650404
Shock. 2005 Jun;23(6):543-8
pubmed: 15897808
Mol Cell Proteomics. 2012 Jan;11(1):M111.010504
pubmed: 21947364
Oncogene. 2003 Oct 2;22(43):6717-24
pubmed: 14555985
Hum Mol Genet. 2014 Jan 1;23(1):24-39
pubmed: 23943793
Science. 1999 Jan 29;283(5402):689-92
pubmed: 9924029
J Cell Sci. 2011 Jan 15;124(Pt 2):171-80
pubmed: 21187344
Essays Biochem. 2018 Jul 20;62(3):443-454
pubmed: 29980631
Neurology. 2013 Nov 19;81(21):1819-26
pubmed: 24142477
Ther Hypothermia Temp Manag. 2017 Sep;7(3):152-161
pubmed: 28437237
Clin Infect Dis. 2010 Sep 1;51(5):591-9
pubmed: 20645860
Antivir Ther. 2007;12(2):205-16
pubmed: 17503663
Int J Mol Med. 2010 Jul;26(1):95-9
pubmed: 20514427
Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R244-52
pubmed: 16987890
Clin Lab. 2015;61(9):1119-28
pubmed: 26554230
J Gen Physiol. 1932 Nov 20;16(2):243-56
pubmed: 19872703
Cell Death Dis. 2018 Jul 20;9(7):735
pubmed: 30026579
J Surg Res. 2006 Jan;130(1):45-51
pubmed: 16154591
J Proteomics. 2015 Sep 8;127(Pt B):352-64
pubmed: 26102536
Curr Genet Med Rep. 2018 Jun;6(2):62-72
pubmed: 30393588
Mol Genet Metab. 2010 Jan;99(1):58-61
pubmed: 19766516
J Agric Food Chem. 2007 Mar 7;55(5):1730-6
pubmed: 17295509
Cell Metab. 2015 May 5;21(5):667-77
pubmed: 25955204
Mol Cell Proteomics. 2007 Jan;6(1):18-28
pubmed: 17018519
Biochimie. 2013 Dec;95(12):2222-8
pubmed: 23770442
Circ Res. 2018 Jan 19;122(2):255-266
pubmed: 29113965
Neurology. 2016 May 24;86(21):2010-5
pubmed: 27164684
Int J Mol Sci. 2019 Aug 09;20(16):
pubmed: 31405033
Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2454-9
pubmed: 23887638
PLoS One. 2015 Mar 30;10(3):e0121692
pubmed: 25822838
Hum Mol Genet. 2010 May 15;19(10):1974-84
pubmed: 20167576
Biochimie. 2018 Dec;155:37-49
pubmed: 29782891
FEBS Lett. 1997 Jul 7;411(1):83-6
pubmed: 9247147
Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17687-92
pubmed: 16301523
Annu Rev Physiol. 2016;78:223-41
pubmed: 26654352
Oncol Rep. 2010 Mar;23(3):779-86
pubmed: 20127020
J Clin Med. 2017 Aug 21;6(8):
pubmed: 28825656
Brain. 2017 Oct 1;140(10):2530-2540
pubmed: 28969370
Diabetes Res Clin Pract. 2015 Jul;109(1):64-70
pubmed: 25998917
Obesity (Silver Spring). 2019 Oct;27(10):1606-1616
pubmed: 31411815
Ann Neurol. 2015 Nov;78(5):814-23
pubmed: 26463265
Int Urol Nephrol. 2016 Jun;48(6):839-44
pubmed: 27043030
Int Immunol. 1995 Mar;7(3):343-52
pubmed: 7794816
J Neural Transm (Vienna). 2005 Sep;112(9):1237-48
pubmed: 15666038
Antimicrob Agents Chemother. 2008 Aug;52(8):2882-9
pubmed: 18474584
BMC Genomics. 2014 Feb 01;15:91
pubmed: 24484525
Annu Rev Genomics Hum Genet. 2010;11:25-44
pubmed: 20690818
Physiol Res. 2011;60(3):521-30
pubmed: 21401303
Nat Genet. 1999 Oct;23(2):147
pubmed: 10508508
Int J Cardiol. 2017 Jan 1;226:53-59
pubmed: 27788390
Nat Rev Dis Primers. 2016 Oct 20;2:16080
pubmed: 27775730
Diabetes. 2007 Apr;56(4):1042-50
pubmed: 17395745
Mol Cells. 2013 Feb;35(2):134-41
pubmed: 23456335
Inflamm Bowel Dis. 2020 May 12;26(6):874-884
pubmed: 31901089
Cold Spring Harb Perspect Biol. 2018 Feb 1;10(2):
pubmed: 28620096
J Hepatol. 2006 Jul;45(1):108-16
pubmed: 16545482
J Antimicrob Chemother. 2011 May;66 Suppl 4:iv7-iv15
pubmed: 21521707
Sci Rep. 2019 Oct 28;9(1):15440
pubmed: 31659173
Biol Cell. 1998 Mar;90(2):161-8
pubmed: 9691433
Arthritis Res Ther. 2018 May 29;20(1):95
pubmed: 29843785
Biochem Biophys Res Commun. 2014 Dec 12;455(3-4):290-7
pubmed: 25446085
Muscle Nerve. 2017 Apr;55(4):564-569
pubmed: 27489983
PLoS One. 2013 Sep 30;8(9):e75981
pubmed: 24098752
J Neural Transm Suppl. 2000;(60):273-6
pubmed: 11205146
Hum Mol Genet. 2010 Oct 15;19(20):3948-58
pubmed: 20656789
Genes Dev. 2012 Feb 1;26(3):271-81
pubmed: 22302939
J Cell Physiol. 2007 May;211(2):364-70
pubmed: 17219405
PLoS One. 2013 Oct 18;8(10):e77077
pubmed: 24204740
Cell Signal. 2007 Oct;19(10):2003-12
pubmed: 17658244
J Clin Endocrinol Metab. 2002 Oct;87(10):4771-4
pubmed: 12364472

Auteurs

Nuria Garrido-Pérez (N)

Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.
Instituto de Investigación Sanitaria (IIS) de Aragón, Av. San Juan Bosco, 13, 50009 Zaragoza, Spain.
Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.
Instituto de Biocomputación y Física de Sistemas Complejos (BIFI), Universidad de Zaragoza, C/Mariano Esquillor (Edificio I + D), 50018 Zaragoza, Spain.

Ana Vela-Sebastián (A)

Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.

Ester López-Gallardo (E)

Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.
Instituto de Investigación Sanitaria (IIS) de Aragón, Av. San Juan Bosco, 13, 50009 Zaragoza, Spain.
Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.

Sonia Emperador (S)

Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.
Instituto de Investigación Sanitaria (IIS) de Aragón, Av. San Juan Bosco, 13, 50009 Zaragoza, Spain.
Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.

Eldris Iglesias (E)

Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.
Instituto de Investigación Sanitaria (IIS) de Aragón, Av. San Juan Bosco, 13, 50009 Zaragoza, Spain.

Patricia Meade (P)

Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.
Instituto de Investigación Sanitaria (IIS) de Aragón, Av. San Juan Bosco, 13, 50009 Zaragoza, Spain.
Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.
Instituto de Biocomputación y Física de Sistemas Complejos (BIFI), Universidad de Zaragoza, C/Mariano Esquillor (Edificio I + D), 50018 Zaragoza, Spain.

Cecilia Jiménez-Mallebrera (C)

Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.
Unidad de Patología Neuromuscular, Departamento de Neuropediatría, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Passeig de Sant Joan de Déu, 2, 08950 Esplugues del Llobregat, Barcelona, Spain.

Julio Montoya (J)

Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.
Instituto de Investigación Sanitaria (IIS) de Aragón, Av. San Juan Bosco, 13, 50009 Zaragoza, Spain.
Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.

M Pilar Bayona-Bafaluy (MP)

Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.
Instituto de Investigación Sanitaria (IIS) de Aragón, Av. San Juan Bosco, 13, 50009 Zaragoza, Spain.
Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.
Instituto de Biocomputación y Física de Sistemas Complejos (BIFI), Universidad de Zaragoza, C/Mariano Esquillor (Edificio I + D), 50018 Zaragoza, Spain.

Eduardo Ruiz-Pesini (E)

Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.
Instituto de Investigación Sanitaria (IIS) de Aragón, Av. San Juan Bosco, 13, 50009 Zaragoza, Spain.
Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.
Fundación ARAID, Av. de Ranillas, 1-D, 50018 Zaragoza, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH